To be honest, I didn't see any new information in the report. We all know that the human trial is planned for Q4 and the other additional plans which were disclosed during CR.
They have hinted that the actual impact of Covid-19 is not yet known and will be assessed soon.
I am a holder and believe in long term capital growth for this stock. But I am not impressed with this report as there is nothing new.
The date for the human trial will have an impact on the SP but it is still unknown. They have only stated significant advancement for the initiation of the initial trial which will be in Q4. Then we need to consider their statement of Covid-19 impact. I just don't want to post all positive news like others for the sake of holding the stock. We need to be realistic.
IBX Price at posting:
9.9¢ Sentiment: Hold Disclosure: Held
